Saturable function of P-glycoprotein as a drug-efflux pump in multidrug-resistant tumour cells

Journal of Pharmacy and Pharmacology

Volumn 48, Issue 5, 1996, Pages 522-525

  Miyamoto, Ken Ichi ^a   Koga Takeda, Keiko ^a   Koga, Kenjiro ^a   Ohshima, Taeyuki ^a   Nomura, Masaaki ^a  

^a HOKURIKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; GLUCOSE; GLYCOPROTEIN P; VINBLASTINE;

ANIMAL CELL; ARTICLE; CELL ENERGY; CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG TRANSPORT; LEUKEMIA P 388; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; TUMOR CELL;

EID: 0029998016     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1996.tb05966.x     Document Type: Article

References (15)

1. Akiyama, S., Cornwell, M. M., Kuwano, M., Pastan, I., Gottesman, M. M. (1988) Most drugs that reverse multidrug resistance also inhibit photoaffinitylabeling of P-glycoprotein by a vinblastine analog. Mol. Pharmacol. 33: 144-147
2. Bellamy, J. L., Meyers, W. S., Dorr, R. T. (1990) The clinical relevance of multidrug resistance. Cancer Invest 8: 547-562
3. Dano, K. (1973) Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells. Biochim. Biophys. Acta 323: 466-483
4. Erlichman, C., Moore, M., Thiessen, J. J., Kerr, I. G., Walker, S., Goodman, P., Bjarnason, G., DeAngelis, C., Bunting, P. (1993) Phase I pharmacokinetic study of cyclosporin A combined with doxorabicin. Cancer Res. 53: 4837-4842
5. Hagiwara, M., Wakusawa, S., Miyamoto, K., Hidaka, H. (1991) Obviation of drug resistance and affinity purification of P-glycoprotein by isoquinolinesulfonamides. Cancer Lett. 60: 103-107
6. Hamada, H., Tsuruo, T. (1988) Characterization of the ATPase activity of the Mr 170,000 to 180,000 membrane glycoprotein (P-glycoprotein) associated with multidrug resistance in K562/ADM cells. Cancer Res. 48: 4926-4932
7. Inaba, M., Kobayashi, H., Sakurai, Y., Johnson, R.K. (1979) Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia. Cancer Res. 39: 2200-2203
8. Johnson, R. K., Ovejera, A. A., Goldin, A. (1976) Activity of anthracyclines against an adriamycin (NSC-123127)-resistant subline of P388 leukemia with special emphasis on cinerubia A (NSC-18334). Cancer Treat. Rep. 60: 99-102
9. Leveille-Webster, C. R., Arias, I. M. (1995) The biology of the Pglycoproteins. J. Membr. Biol. 143: 89-102
10. Miyamoto, K., Wakusawa, S., Nakamura, S. (1992) Drug resistance dependent on different molecular size P-glycoprotein in Yoshida rat ascites hepatoma cells. Biochem. Pharmacol. 43: 1143-1145
11. Miyamoto, K., Inoko, K., Wakusawa, S., Kajita, S., Hasegawa, T., Takagi, K., Koyama, M. (1993) Inhibition of multidrug resistance by a new staurosporine derivative, NA-382, in vitro and in vivo. Cancer Res. 53: 1555-1559
12. Miyamoto, K.-I., Takeda, K., Koga, K., Ohshima, T., Wakusawa, S. (1995) Antitumour effects and pharmacokinetics of combination of vinblastine with a staurosporine derivative, NA-382, in P388/ADR-bearing mice. J. Pharm. Pharmacol. 47: 524-529
13. Riordan, R., Ling, V. (1985) Genetic and biochemical characterization of multidrug resistance. Pharmacol. Ther. 28: 51-57
14. Wakusawa, S., Nakamura, S., Inoko, K., Miyamoto, K. (1992) Sensitivity to antitumor drugs and vinblastine binding to membrane in rat ascites hepatoma AH66 cells. Chem. Pharm. Bull. 40: 2182-2184
15. Yoshida, T. (1956) Contributions of the ascites hepatoma to the concept of malignancy of cancer. Ann. N Y Acad. Sci. 63: 852-881